| Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI CA Hamm, CJ Wang, LJ Savic, M Ferrante, I Schobert, T Schlachter, ... European radiology 29, 3338-3347, 2019 | 257 | 2019 |
| Predicting treatment response to intra-arterial therapies for hepatocellular carcinoma with the use of supervised machine learning—an artificial intelligence concept A Abajian, N Murali, LJ Savic, FM Laage-Gaupp, N Nezami, JS Duncan, ... Journal of Vascular and Interventional Radiology 29 (6), 850-857. e1, 2018 | 160 | 2018 |
| Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features CJ Wang, CA Hamm, LJ Savic, M Ferrante, I Schobert, T Schlachter, ... European radiology 29, 3348-3357, 2019 | 130 | 2019 |
| Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis J Chapiro, LD Wood, MD Lin, R Duran, T Cornish, D Lesage, V Charu, ... Radiology 273 (3), 746-758, 2014 | 120 | 2014 |
| Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE IT Schobert, LJ Savic, J Chapiro, K Bousabarah, E Chen, F Laage-Gaupp, ... European radiology 30, 5663-5673, 2020 | 90 | 2020 |
| Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to … J Chapiro, R Duran, MD Lin, R Schernthaner, D Lesage, Z Wang, ... European radiology 25, 1993-2003, 2015 | 71 | 2015 |
| Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options … D Do Minh, J Chapiro, B Gorodetski, Q Huang, C Liu, S Smolka, LJ Savic, ... European radiology 27, 4995-5005, 2017 | 68 | 2017 |
| Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer J Chapiro, S Sur, LJ Savic, S Ganapathy-Kanniappan, J Reyes, R Duran, ... Clinical Cancer Research 20 (24), 6406-6417, 2014 | 64 | 2014 |
| Automated detection and delineation of hepatocellular carcinoma on multiphasic contrast-enhanced MRI using deep learning K Bousabarah, B Letzen, J Tefera, L Savic, I Schobert, T Schlachter, ... Abdominal Radiology 46, 216-225, 2021 | 62 | 2021 |
| Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects LJ Savic, J Chapiro, JFH Geschwind Hepatobiliary Surgery and Nutrition 6 (1), 7, 2017 | 53 | 2017 |
| Deep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver PM Oestmann, CJ Wang, LJ Savic, CA Hamm, S Stark, I Schobert, ... European radiology 31, 4981-4990, 2021 | 50 | 2021 |
| Irreversible electroporation in interventional oncology: where we stand and where we go LJ Savic, J Chapiro, B Hamm, B Gebauer, F Collettini RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2016 | 49 | 2016 |
| Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial … R Duran, J Chapiro, C Frangakis, MD Lin, TR Schlachter, ... Translational oncology 7 (4), 447-455, 2014 | 45 | 2014 |
| Molecular imaging of extracellular tumor pH to reveal effects of locoregional therapy on liver cancer microenvironment LJ Savic, IT Schobert, D Peters, JJ Walsh, FM Laage-Gaupp, CA Hamm, ... Clinical Cancer Research 26 (2), 428-438, 2020 | 43 | 2020 |
| Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner D Coman, DC Peters, JJ Walsh, LJ Savic, S Huber, AJ Sinusas, MD Lin, ... Magnetic resonance in medicine 83 (5), 1553-1564, 2020 | 36 | 2020 |
| Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model JMM Van Breugel, JF Geschwind, S Mirpour, LJ Savic, X Zhang, R Duran, ... Theranostics 9 (13), 3674, 2019 | 34 | 2019 |
| Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond? LJ Savic, J Chapiro, G Duwe, JF Geschwind Hepatic oncology 3 (1), 19-28, 2016 | 33 | 2016 |
| Primary neuroendocrine neoplasms of the breast: case series and literature review B Özdirik, A Kayser, A Ullrich, LJ Savic, M Reiss, F Tacke, B Wiedenmann, ... Cancers 12 (3), 733, 2020 | 28 | 2020 |
| Lipiodol as an imaging biomarker of tumor response after conventional transarterial chemoembolization: prospective clinical validation in patients with primary and secondary … MA Miszczuk, J Chapiro, JFH Geschwind, V Thakur, N Nezami, ... Translational Oncology 13 (3), 100742, 2020 | 28 | 2020 |
| Ablation of intrahepatic cholangiocarcinoma J Sweeney, N Parikh, G El-Haddad, B Kis Seminars in Interventional Radiology 36 (04), 298-302, 2019 | 24 | 2019 |
Jean-Francois GeschwindUSA Vein Clinics and Oncology CentersVerified email at syntactx.com
